Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug. Translational Medicine Reports, [S. l.], v. 4, n. 1, 2017. DOI: 10.4081/tmr.6596. Disponível em: https://www.pagepressjournals.org/tmr/article/view/6596. Acesso em: 24 jun. 2026.